Category: Drug 483s
Inspection date range: 11/8/11-12/12/11
Company: IntelliCell Biosciences, Inc.
30 East 76th St.
New York, NY 10021
Inspector(s): Irina Gaberman
Observations: Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and written.